Literature DB >> 16687448

Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase.

Tetsuya Koide1, Tadayoshi Hayata, Ken W Y Cho.   

Abstract

Cholesterol regulates Hedgehog (Hh) signaling during early vertebrate development. Smith-Lemli-Opitz syndrome (SLOS) is caused by defects in 7-dehydrocholesterol reductase (DHCR7), an enzyme catalyzing the final step of cholesterol biosynthesis. Many developmental malformations attributed to SLOS occur in tissues and organs where Hh signaling is required for development, but the precise role of DHCR7 deficiency in this disease remains murky. We report that DHCR7 and Sonic Hedgehog (Shh) are co-expressed during midline development in Xenopus embryos. DHCR7 has previously been implicated to function as a positive regulator of Hh signaling that acts to regulate the cholesterol adduction of Hh ligand or to affect Hh signaling in the responding cell. We present gain- and loss-of-function analyses suggesting that DHCR7 functions as a negative regulator of Hh signaling at the level or downstream of Smoothened (Smo) and affects intracellular Hh signaling. Our analysis also raises the possibility that the human condition SLOS is caused not only by disruption of the enzymatic role of DHCR7 as a reductase in cholesterol biosynthesis, but may also involve defects in DHCR7 resulting in derepression of Shh signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687448     DOI: 10.1242/dev.02393

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  24 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  The conserved Rieske oxygenase DAF-36/Neverland is a novel cholesterol-metabolizing enzyme.

Authors:  Takuji Yoshiyama-Yanagawa; Sora Enya; Yuko Shimada-Niwa; Shunsuke Yaguchi; Yoshikazu Haramoto; Takeshi Matsuya; Kensuke Shiomi; Yasunori Sasakura; Shuji Takahashi; Makoto Asashima; Hiroshi Kataoka; Ryusuke Niwa
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.

Authors:  Zeljka Korade; Hye-Young H Kim; Keri A Tallman; Wei Liu; Katalin Koczok; Istvan Balogh; Libin Xu; Karoly Mirnics; Ned A Porter
Journal:  J Med Chem       Date:  2016-01-29       Impact factor: 7.446

Review 4.  Hedgehog signaling and steroidogenesis.

Authors:  Isabella Finco; Christopher R LaPensee; Kenneth T Krill; Gary D Hammer
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 5.  Genetic basis of congenital cardiovascular malformations.

Authors:  Seema R Lalani; John W Belmont
Journal:  Eur J Med Genet       Date:  2014-04-30       Impact factor: 2.708

6.  Disruption of sonic hedgehog signaling in Ellis-van Creveld dwarfism confers protection against bipolar affective disorder.

Authors:  E I Ginns; M Galdzicka; R C Elston; Y E Song; S M Paul; J A Egeland
Journal:  Mol Psychiatry       Date:  2014-10-14       Impact factor: 15.992

7.  Members of the Rusc protein family interact with Sufu and inhibit vertebrate Hedgehog signaling.

Authors:  Zhigang Jin; Tyler Schwend; Jia Fu; Zehua Bao; Jing Liang; Huimin Zhao; Wenyan Mei; Jing Yang
Journal:  Development       Date:  2016-09-15       Impact factor: 6.868

8.  Statins for Smith-Lemli-Opitz syndrome.

Authors:  Rami A Ballout; Simona Bianconi; Alicia Livinski; Yi-Ping Fu; Alan T Remaley; Forbes D Porter
Journal:  Cochrane Database Syst Rev       Date:  2020

9.  Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

Authors:  Katie T Jenkins; Louise S Merkens; Matthew R Tubb; Leslie Myatt; W Sean Davidson; Robert D Steiner; Laura A Woollett
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

10.  Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.

Authors:  Carlos A Orozco; Neus Martinez-Bosch; Pedro E Guerrero; Judith Vinaixa; Tomás Dalotto-Moreno; Mar Iglesias; Mireia Moreno; Magdolna Djurec; Françoise Poirier; Hans-Joachim Gabius; Martin E Fernandez-Zapico; Rosa F Hwang; Carmen Guerra; Gabriel A Rabinovich; Pilar Navarro
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.